Low bandgap high entropy alloy for visible light-assisted photocatalytic degradation of pharmaceutically active compounds: Performance assessment and mechanistic insights

The incessant accumulation of pharmaceutically active compounds (PhACs) in various environmental compartments represents a global menace. Herein, an equimolar high entropy alloy (HEA), i.e., FeCoNiCuZn, is synthesized via a facile and scalable method, and its effectiveness in eliminating four different PhACs from aqueous matrices is rigorously examined. Attributing to its relatively low bandgap and multielement active sites, the as-synthesized quinary HEA demonstrates more pronounced photocatalytic decomposition efficiency, towards tetracycline (86%), sulfamethoxazole (94%), ibuprofen (80%), and diclofenac (99%), than conventional semiconductor-based photocatalysts, under visible light irradiation. Additionally, radical trapping assays are conducted, and the dissociation intermediates are identified, to probe the plausible photocatalytic degradation pathways. Further, the end-products of FeCoNiCuZn-mediated photocatalysis are apparently non-toxic, and the HEA can be successfully recycled repeatedly, with no obvious leaching of heavy metal ions. Overall, the findings of this study testify the applicability of FeCoNiCuZn as a visible light-active photocatalyst, for treating wastewaters contaminated with PhACs. [Display omitted] •An equimolar FeCoNiCuZn high entropy alloy (HEA) is synthesized by induction melting.•The quinary HEA can effectively degrade pharmaceutical residues under visible light.•The plausible photocatalytic degradation mechanism is investigated and proposed.•The photocatalysis end-products do not present any imminent threat to human health.•The HEA exhibits extraordinary stability for repeated usage.